08:45 AM EST, 11/12/2024 (MT Newswires) -- Novavax ( NVAX ) reported a Q3 loss Tuesday of $0.76 per diluted share, narrower than the loss of $1.26 a year earlier.

Four analysts polled by Capital IQ expected a loss of $0.81.

Revenue for the quarter ended Sept. 30 was $84.5 million, down from $187 million a year earlier.

Five analysts surveyed by Capital IQ expected $73.8 million.

The company said it now expects 2024 revenue between $650 million and $700 million, down from a previous guidance of between $700 million and $800 million. Analysts polled by Capital IQ expect $762.5 million.

Shares of the company were down over 13% in recent premarket activity.

Price: 8.30, Change: -0.71, Percent Change: -7.88